This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sharp, W. J. Articles by Kresowik, T. F. Search for Related Content PubMed Articles by Sharp, W. J. Articles by Kresowik, T. F. Social Bookmarking                         What's this?

Are Patients Receiving Maximal Medical Therapy Following Carotid Endarterectomy?

Timothy F. Kresowik, MD

Division of Vascular Surgery, University of Iowa Health Care, 200 Hawkins Drive, Iowa City, IA 52242

The authors used clams data from Blue Cross and Blue Shield Michigan for a 3-year period to study usage of antihypertensive and antiplatelet agents. and statins, after carotid endarterectomy and compared it with results from the North American Symptomatic Carotid Endarterectormy Trial (NASCET). Prescription of drugs and use for a sustained 1- year period was exam ned. They found the statin prescription rate was 70%, 66%, and 73%6 for the 3 study years and the average sustained statin use was 38%. Use of antiplatelet medications (5%) and angiotensin-converting enzyme inhibitors (19%) was aiso low. The authors concluded that statin use has ncreased after carotid endarterectomy compared with NASCET but remains below 40%.

Key Words: carotid endarterectomy • statins • antiplatelet drugs • antihypertensive drugs

Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 17, No. 3, 272-1-273 (2005)
DOI: 10.1177/153100350501700322


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?